SCHEMBL7863619

SCHEMBL7863619

CCNc1ccc(OC)c(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.59
BCL6 P41182 1/20 0.54
GAA P10253 3/20 0.54
MAPT P10636 9/20 0.52
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 9/20 0.52
MAPK1 P28482 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
PGK1 P00558 1/20 0.50
GSK3B P49841 1/20 0.50
MAP4K2 Q12851 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
TP53 P04637 1/20 0.49
PKM P14618 1/20 0.49
HPGD P15428 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21892023 0.85 PGK1 (0.50) HTTBCL6GAAMAPTMEN1
SCHEMBL30480119 0.82 MAPT (0.56) HTTGAAMAPTMEN1KMT2A
SCHEMBL423387 0.82 MAPT (0.56) HTTGAAMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL5123360 0.81 MAPT (0.54) HTTGAAMAPTMEN1KMT2A
Bromide SCHEMBL11715283 0.81 MAPT (0.54) HTTGAAMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL7102293 0.81 MAPT (0.54) HTTGAAMAPTMEN1KMT2A
SCHEMBL4573754 0.81 SUV39H2 (0.52) HTTBCL6GAAMAPTMEN1
SCHEMBL20714770 0.81 GAA (0.50) HTTBCL6GAAMAPTMEN1
SCHEMBL8322708 0.80 MAPT (0.57) HTTGAAMAPTMEN1KMT2A
SCHEMBL19089346 0.80 PGK1 (0.55) HTTBCL6GAAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP disclosed
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same YUHAN CORPORATION (KR) 2019-08-20 US disclosed
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same YUHAN CORPORATION (KR) 2019-05-16 US disclosed
EP-3483149-A1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Yuhan Corporation (KR) 2019-05-15 EP disclosed
US-8304406-B2 Compounds for treating pulmonary hypertension BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-11-06 US disclosed
US-20100113452-A1 COMPOUNDS FOR TREATING PULMONARY HYPERTENSION BAYER HEALTHCARE AG (DE) 2010-05-06 US disclosed
EP-1137632-A1 THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2001-10-04 EP disclosed
WO-2000034238-A1 THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same ILK, SBDS, BDKRB1 HTT 3134/4885BCL6 2259/4885GAA 4292/4885
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same ILK, SBDS, BDKRB1 HTT 3134/4885BCL6 2259/4885GAA 4292/4885
US-20100113452-A1 COMPOUNDS FOR TREATING PULMONARY HYPERTENSION PTGIR, PTGIS, EDNRB HTT 4102/4885BCL6 4235/4885GAA 3943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.